Equibles does not estimate personal net worth.
Get an email with a short summary when West Pharmaceutical Services Inc publishes a filing, an earnings call transcript or a press release.
Get WST alertsMichel Lagarde is recorded as Board Member and CEO at West Pharmaceutical Services Inc (WST) since August 31, 2026. West Pharmaceutical Services Inc reported in an 8-K filed June 1, 2026 that Michel Lagarde was appointed member of the Board, effective August 31, 2026. West Pharmaceutical Services Inc reported in an 8-K filed June 1, 2026 that Michel Lagarde was appointed President and Chief Executive Officer, effective August 31, 2026. Michel Lagarde has spoken on 1 earnings call across 1 company, most recently for West Pharmaceutical Services Inc on October 29, 2026. West Pharmaceutical Services Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at West Pharmaceutical Services Inc includes Robert F. Friel (Chairman and Board Member), Kimberly Banks MacKay (General Counsel), Chad R. Winters (Chief Accounting Officer) and 7 others.
“As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.”
“On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the "Start Date"), to replace Mr. Green in those roles.”
“I'm very pleased to welcome you to our earnings call, and before getting into the details of our strong third-quarter performance, I want to begin by saying what a privilege it is for me to now be part of Team West.”
2026-08-31–present
2026-08-31–present
Medical Instruments & Supplies · Healthcare
Board Member, CEO
2026-08-31–present
